Stock chart
Ticker: BBIO Exchange: NSM


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2025-06-11 2025-06-10 PS Planned sale

Valantine Hannah

Non-Executive Director
1,000 -70.9%
40.00
USD 171,680
1,000 -70.9% 40.00 USD 100,000
2025-05-20 2025-05-20 PS Planned sale

Kumar Neil

Chief Executive Officer

Executive Director
75,000 -1.5%
33.40
USD 2,504,978
75,000 -1.5% 33.40 USD 2,504,978
2025-05-20 2025-05-19 PS Planned sale

Kumar Neil

Chief Executive Officer

Executive Director
400 -0.2%
33.75
USD 13,499
400 -0.2% 33.75 USD 13,499
2025-05-20 2025-05-19 PS Planned sale

Kumar Neil

Chief Executive Officer

Executive Director
25,756 -10.6%
33.32
USD 858,265
25,756 -10.6% 33.32 USD 858,265
2025-05-14 2025-05-12 S Sale

KKR Genetic Disorder L.P.

Large shareholder
6,000,000 -31.2%
34.20
USD 205,200,000
6,000,000 -31.2% 34.20 USD 205,200,000
2025-05-06 2025-05-02 S Sale

Apuli Maricel

Chief Accounting Officer

Officer
1,026 -0.7%
38.51
USD 39,509
1,026 -0.7% 38.51 USD 39,509
2025-05-06 2025-05-02 S Sale

Lo Andrew

Non-Executive Director
100,000 -48.6%
38.50
USD 3,849,900
100,000 -48.6% 38.50 USD 3,849,900
2025-04-24 2025-04-22 PS Planned sale

Kumar Neil

Chief Executive Officer

Executive Director
75,000 -1.5%
34.11
USD 2,558,025
75,000 -1.5% 34.11 USD 2,558,025
2025-04-16 2025-04-14 PS Planned sale

Ellis Andrea

Non-Executive Director
10,000 -45.5%
35.00
USD 350,000
10,000 -45.5% 35.00 USD 350,000
2025-04-03 2025-04-01 PS Planned sale

Ellis Andrea

Non-Executive Director
30,000 -71.4%
34.05
USD 1,021,500
30,000 -71.4% 34.05 USD 1,021,500
2025-03-27 2025-03-25 PS Planned sale

Kumar Neil

Chief Executive Officer

Executive Director
75,000 -1.5%
36.87
USD 2,764,943
75,000 -1.5% 36.87 USD 2,764,943
2025-03-10 2025-03-06 PS Planned sale

Valantine Hannah

Non-Executive Director
12,875 -87.9%
32.58
USD 419,500
12,875 -87.9% 32.58 USD 419,500
2025-03-07 2025-03-05 S Sale

KKR Genetic Disorder L.P.

Large shareholder
6,000,000 -23.8%
32.96
USD 197,760,000
6,000,000 -23.8% 32.96 USD 197,760,000
2025-02-27 2025-02-25 PS Planned sale

STEPHENSON BRIAN C

CFO and Treasurer

Officer
100 -0.1%
34.18
USD 3,418
100 -0.1% 34.18 USD 3,418
2025-02-27 2025-02-25 PS Planned sale

STEPHENSON BRIAN C

CFO and Treasurer

Officer
8,400 -7.6%
33.18
USD 278,697
8,400 -7.6% 33.18 USD 278,697
2025-02-27 2025-02-25 PS Planned sale

Kumar Neil

Chief Executive Officer

Executive Director
37,101 -0.7%
33.79
USD 1,253,524
37,101 -0.7% 33.79 USD 1,253,524
2025-02-27 2025-02-25 PS Planned sale

Kumar Neil

Chief Executive Officer

Executive Director
37,899 -0.7%
33.36
USD 1,264,447
37,899 -0.7% 33.36 USD 1,264,447
2025-02-19 2025-02-19 PS Planned sale

STEPHENSON BRIAN C

Secretary, Treasurer & CFO

Officer
4,148 -3.9%
36.16
USD 149,973
4,148 -3.9% 36.16 USD 149,973
2025-02-19 2025-02-19 PS Planned sale

Kumar Neil

Chief Executive Officer

Executive Director
76 -0.0%
36.56
USD 2,779
76 -0.0% 36.56 USD 2,779
2025-02-19 2025-02-19 PS Planned sale

Kumar Neil

Chief Executive Officer

Executive Director
31,467 -12.9%
36.14
USD 1,137,246
31,467 -12.9% 36.14 USD 1,137,246
// ... existing code ...